Vincerx Pharma, Inc. (VINC)
OTCMKTS
· Delayed Price · Currency is USD
0.0575
-0.0101 (-14.94%)
At close: Apr 25, 2025
Vincerx Pharma Employees
As of December 31, 2024, Vincerx Pharma had 13 total employees, including 12 full-time and 1 part-time employees. The number of employees decreased by 29 or -69.05% compared to the previous year.
Employees
13
Change (1Y)
-29
Growth (1Y)
-69.05%
Revenue / Employee
n/a
Profits / Employee
-$2,313,385
Market Cap
300.97K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13 | -29 | -69.05% |
Dec 31, 2023 | 42 | 1 | 2.44% |
Dec 31, 2022 | 41 | -15 | -26.79% |
Dec 31, 2021 | 56 | 28 | 100.00% |
Dec 31, 2020 | 28 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Vincerx Pharma News
- 10 days ago - Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewsWire
- 19 days ago - Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - GlobeNewsWire
- 5 weeks ago - Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewsWire
- 2 months ago - Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - GlobeNewsWire
- 3 months ago - Vincerx Pharma, Inc. Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC - Business Wire
- 4 months ago - VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders - Business Wire
- 4 months ago - Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire